CLINICAL TRIALS PROFILE FOR SAFFLOWER OIL
✉ Email this page to a colleague
All Clinical Trials for Safflower Oil
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004420 ↗ | Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis | Completed | University of Massachusetts, Worcester | N/A | 1994-09-01 | OBJECTIVES: I. Determine the efficacy and safety of gammalinolenic acid in the treatment of childhood arthritis. |
| NCT00004420 ↗ | Study of Gammalinolenic Acid for Juvenile Rheumatoid Arthritis | Completed | FDA Office of Orphan Products Development | N/A | 1994-09-01 | OBJECTIVES: I. Determine the efficacy and safety of gammalinolenic acid in the treatment of childhood arthritis. |
| NCT00204932 ↗ | Effects of CLA Supplements on Body Weight and Fat Oxidation | Completed | University of Wisconsin, Madison | Phase 2 | 2004-07-01 | Conjugated linoleic acid (CLA) is form of fat found in dairy foods, beef and other natural sources. When given to small animals, decreases of body fat have been noted.. Although weight loss is the best treatment for overweight and obesity, it is difficult to maintain the loss in the long term. Because of this, treatment emphasis has turned to small weight losses obtained through non-restrictive diets and prevention of weight regain. This is a study to determine if 6 months of consumption a purified form of CLA will result in greater loss of body fat than control and to determine whether CLA consumption increases total fat oxidation, which would help explain why the weight loss occurs. |
| NCT00396461 ↗ | ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients | Terminated | B. Braun Medical SA | Phase 4 | 2006-11-01 | This study aims to analyse the effect of two total parenteral nutrition diets with lipid emulsions of different compositions on the incidence of nosocomial infection in critical patients. One diet will contain an MCT/LCT emulsion concentrated to 20% (50:50 ratio) and the other will comprise an MCT/LCT/fish oil emulsion (50:40:10 ratio). The secondary objective of this study is to analyse mortality in hospital and up to 6 months of discharge. |
| NCT00682318 ↗ | Effects of Fish Oil and Red Wine on Oxidative Stress Biomarkers | Active, not recruiting | American Heart Association | N/A | 2008-05-01 | The American Heart Association and the American College of Cardiology (AHA/ACC) recently encouraged "increased consumption of omega-3 fatty acids in the form of fish or capsule form (1 g/day) for risk reduction" and stated that "for treatment of elevated triglycerides, higher doses are usually necessary for risk reduction" (Smith SC et al. Circulation 2006;113:2363-72). These recommendations are based on conflicting evidence about the efficacy of the omega-3 treatment with data derived from single randomized trials or non-randomized studies (Smith SC et al. Circulation 2006;113:2363-72). Much effort has been undertaken to elucidate the role of omega-3 fatty acids in the development of cardiovascular disease, but even recent meta-analyses deliver no clear picture; they either favor (Mozaffarian D Jama 2006;296:1885-99) or reject (Hooper L Bmj 2006;332:752-60) the hypothesis of cardioprotective effects of omega-3 FAs. The objective of the clinical study is to study the effects of fish oil on blood and urinary markers of inflammation and cell stress. By using different permutations of high-dose supplementation of omega-3 and omega-6 fatty acids versus different alimentary omega-3 fish doses and grain alcohol versus different kinds of red wine, this trial will study how omega-3 fatty acids, ethanol and red wine constituents modulate biomarkers of inflammation and cell stress. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Safflower Oil
Condition Name
Clinical Trial Locations for Safflower Oil
Trials by Country
Clinical Trial Progress for Safflower Oil
Clinical Trial Phase
Clinical Trial Sponsors for Safflower Oil
Sponsor Name
